Transforming growth factor-beta1 in inflammatory airway disease: A key for understanding inflammation and remodeling

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 67, Issue 10, 2012, Pages 1193-1202

  Yang, Y C ^a,b   Zhang, N ^a   Van Crombruggen, K ^a   Hu, G H ^b   Hong, S L ^b   Bachert, C ^a  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

^b CHONGQING MEDICAL UNIVERSITY   (China)

Author keywords

airway disease; inflammation; remodeling; transforming growth factor beta

Indexed keywords

TRANSFORMING GROWTH FACTOR BETA1;

ARTICLE; ASTHMA; CHRONIC OBSTRUCTIVE LUNG DISEASE; CHRONIC RHINOSINUSITIS; HUMAN; NONHUMAN; PRIORITY JOURNAL; RESPIRATORY TRACT INFLAMMATION;

AIRWAY REMODELING; ASTHMA; HUMANS; INFLAMMATION; TRANSFORMING GROWTH FACTOR BETA1;

EID: 84866461090     PISSN: 01054538     EISSN: 13989995     Source Type: Journal    
DOI: 10.1111/j.1398-9995.2012.02880.x     Document Type: Article

References (101)

1. Jarvis D, Newson R, Lotvall J, Hastan D, Tomassen P, Keil T, et al. Asthma in adults and its association with chronic rhinosinusitis: the GA(2) LEN survey in Europe. Allergy 2012; 67: 91-98.
2. Vandenplas O, Dramaix M, Joos G, Louis R, Michils A, Verleden G, et al. The impact of concomitant rhinitis on asthma-related quality of life and asthma control. Allergy 2010; 65: 1290-1297.
3. Guilemany JM, Angrill J, Alobid I, Centellas S, Prades E, Roca J, et al. United airways: the impact of chronic rhinosinusitis and nasal polyps in bronchiectasic patient's quality of life. Allergy 2009; 64: 1524-1529.
4. Foreman A, Holtappels G, Psaltis AJ, Jervis-Bardy J, Field J, Wormald PJ, et al. Adaptive immune responses in Staphylococcus aureus biofilm-associated chronic rhinosinusitis. Allergy 2011; 66: 1449-1456.
5. Kowalski ML, Cieslak M, Perez-Novo CA, Makowska JS, Bachert C,. Clinical and immunological determinants of severe/refractory asthma (SRA): association with Staphylococcal superantigen-specific IgE antibodies. Allergy 2011; 66: 32-38.
6. Zhang N, Holtappels G, Gevaert P, Patou J, Dhaliwal B, Gould H, et al. Mucosal tissue polyclonal IgE is functional in response to allergen and SEB. Allergy 2011; 66: 141-148.
7. Krysko O, Holtappels G, Zhang N, Kubica M, Deswarte K, Derycke L, et al. Alternatively activated macrophages and impaired phagocytosis of S. aureus in chronic rhinosinusitis. Allergy 2011; 66: 396-403.
8. Salib RJ, Howarth PH,. Transforming growth factor-beta in allergic inflammatory disease of the upper airways: friend or foe? Clin Exp Allergy 2009; 39: 1128-1135.
9. Halwani R, Al-Muhsen S, Al-Jahdali H, Hamid Q,. Role of transforming growth factor-beta in airway remodeling in asthma. Am J Respir Cell Mol Biol 2011; 44: 127-133.
10. Konigshoff M, Kneidinger N, Eickelberg O,. TGF-beta signaling in COPD: deciphering genetic and cellular susceptibilities for future therapeutic regimen. Swiss Med Wkly 2009; 139: 554-563.
11. Van Bruaene N, Bachert C,. Tissue remodeling in chronic rhinosinusitis. Curr Opin Allergy Clin Immunol 2011; 11: 8-11.
12. Van Bruaene N, Novo CP, Van Crombruggen K, Deruyck N, Holtappels G, Van Cauwenberge P, et al. Inflammation and remodelling patterns in early stage chronic rhinosinusitis. Clin Exp Allergy 2011; doi: 10.1111/j.1365-2222.2011. 03898.x. [Epub ahead of print]
13. Shi M, Zhu J, Wang R, Chen X, Mi L, Walz T, et al. Latent TGF-beta structure and activation. Nature 2011; 474: 343-349.
14. Klass BR, Grobbelaar AO, Rolfe KJ,. Transforming growth factor beta1 signalling, wound healing and repair: a multifunctional cytokine with clinical implications for wound repair, a delicate balance. Postgrad Med J 2009; 85: 9-14.
15. Li MO, Wan YY, Sanjabi S, Robertson AK, Flavell RA,. Transforming growth factor-beta regulation of immune responses. Annu Rev Immunol 2006; 24: 99-146.
16. Hyytiainen M, Penttinen C, Keski-Oja J,. Latent TGF-beta binding proteins: extracellular matrix association and roles in TGF-beta activation. Crit Rev Clin Lab Sci 2004; 41: 233-264. (Pubitemid 38888060)
17. Annes JP, Munger JS, Rifkin DB,. Making sense of latent TGFbeta activation. J Cell Sci 2003; 116 (Pt 2): 217-224. (Pubitemid 36163863)
18. Koli K, Myllarniemi M, Keski-Oja J, Kinnula VL,. Transforming growth factor-beta activation in the lung: focus on fibrosis and reactive oxygen species. Antioxid Redox Signal 2008; 10: 333-342.
19. Derynck R, Zhang YE,. Smad-dependent and Smad-independent pathways in TGF-beta family signalling. Nature 2003; 425: 577-584. (Pubitemid 37280136)
20. Yoshimura A, Wakabayashi Y, Mori T,. Cellular and molecular basis for the regulation of inflammation by TGF-beta. J Biochem 2010; 147: 781-792.
21. Bettelli E, Carrier Y, Gao W, Korn T, Strom TB, Oukka M, et al. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 2006; 441: 235-238.
22. Veldhoen M, Uyttenhove C, van Snick J, Helmby H, Westendorf A, Buer J, et al. Transforming growth factor-beta 'reprograms' the differentiation of T helper 2 cells and promotes an interleukin 9-producing subset. Nat Immunol 2008; 9: 1341-1346.
23. Wahl SM,. Transforming growth factor-beta: innately bipolar. Curr Opin Immunol 2007; 19: 55-62. (Pubitemid 46073697)
24. Li MO, Wan YY, Flavell RA,. T cell-produced transforming growth factor-beta1 controls T cell tolerance and regulates Th1- and Th17-cell differentiation. Immunity 2007; 26: 579-591. (Pubitemid 46756347)
25. Li MO, Sanjabi S, Flavell RA,. Transforming growth factor-beta controls development, homeostasis, and tolerance of T cells by regulatory T cell-dependent and -independent mechanisms. Immunity 2006; 25: 455-471. (Pubitemid 44354214)
26. Van Bruaene N, Perez-Novo CA, Basinski TM, Van Zele T, Holtappels G, De Ruyck N, et al. T-cell regulation in chronic paranasal sinus disease. J Allergy Clin Immunol 2008; 121: 1435-1441, 1441 e1-3.
27. Dardalhon V, Awasthi A, Kwon H, Galileos G, Gao W, Sobel RA, et al. IL-4 inhibits TGF-beta-induced Foxp3 + T cells and, together with TGF-beta, generates IL-9 + IL-10 + Foxp3(-) effector T cells. Nat Immunol 2008; 9: 1347-1355.
28. Tran DQ,. TGF-beta: the sword, the wand, and the shield of FOXP3(+) regulatory T cells. J Mol Cell Biol 2012; 4: 29-37.
29. Shull MM, Ormsby I, Kier AB, Pawlowski S, Diebold RJ, Yin M, et al. Targeted disruption of the mouse transforming growth factor-beta 1 gene results in multifocal inflammatory disease. Nature 1992; 359: 693-699.
30. Crosby LM, Waters CM,. Epithelial repair mechanisms in the lung. Am J Physiol Lung Cell Mol Physiol 2010; 298: L715-L731.
31. Kitamura H, Cambier S, Somanath S, Barker T, Minagawa S, Markovics J, et al. Mouse and human lung fibroblasts regulate dendritic cell trafficking, airway inflammation, and fibrosis through integrin alphavbeta8-mediated activation of TGF-beta. J Clin Invest 2011; 121: 2863-2875.
32. Semlali A, Jacques E, Rouabhia M, Milot J, Laviolette M, Chakir J,. Regulation of epithelial cell proliferation by bronchial fibroblasts obtained from mild asthmatic subjects. Allergy 2010; 65: 1438-1445.
33. Baarsma HA, Spanjer AI, Haitsma G, Engelbertink LH, Meurs H, Jonker MR, et al. Activation of WNT/beta-catenin signaling in pulmonary fibroblasts by TGF-beta(1) is increased in chronic obstructive pulmonary disease. PLoS ONE 2011; 6: e25450.
34. Park IH, Park SJ, Cho JS, Moon YM, Moon JH, Kim TH, et al. Effect of simvastatin on transforming growth factor beta-1-induced myofibroblast differentiation and collagen production in nasal polyp-derived fibroblasts. Am J Rhinol Allergy 2012; 26: 7-11.
35. Park HH, Park IH, Cho JS, Lee YM, Lee HM,. The effect of macrolides on myofibroblast differentiation and collagen production in nasal polyp-derived fibroblasts. Am J Rhinol Allergy 2010; 24: 348-353.
36. Nonaka M, Pawankar R, Fukumoto A, Yagi T,. Heterogeneous response of nasal and lung fibroblasts to transforming growth factor-beta 1. Clin Exp Allergy 2008; 38: 812-821. (Pubitemid 351550671)
37. Camara J, Jarai G,. Epithelial-mesenchymal transition in primary human bronchial epithelial cells is Smad-dependent and enhanced by fibronectin and TNF-alpha. Fibrogenesis Tissue Repair 2010; 3: 2.
38. Hackett TL, Warner SM, Stefanowicz D, Shaheen F, Pechkovsky DV, Murray LA, et al. Induction of epithelial-mesenchymal transition in primary airway epithelial cells from patients with asthma by transforming growth factor-beta1. Am J Respir Crit Care Med 2009; 180: 122-133.
39. Willis BC, Borok Z,. TGF-beta-induced EMT: mechanisms and implications for fibrotic lung disease. Am J Physiol Lung Cell Mol Physiol 2007; 293: L525-L534. (Pubitemid 47358808)
40. Watelet JB, Bachert C, Claeys C, Van Cauwenberge P,. Matrix metalloproteinases MMP-7, MMP-9 and their tissue inhibitor TIMP-1: expression in chronic sinusitis vs nasal polyposis. Allergy 2004; 59: 54-60. (Pubitemid 38167952)
41. Ohbayashi H, Shimokata K,. Matrix metalloproteinase-9 and airway remodeling in asthma. Curr Drug Targets Inflamm Allergy 2005; 4: 177-181. (Pubitemid 40873100)
42. Van Bruaene N, Derycke L, Perez-Novo CA, Gevaert P, Holtappels G, De Ruyck N, et al. TGF-beta signaling and collagen deposition in chronic rhinosinusitis. J Allergy Clin Immunol 2009; 124: 253-259, 259 e1-2.
43. Sejima T, Holtappels G, Bachert C,. The expression of fibrinolytic components in chronic paranasal sinus disease. Am J Rhinol Allergy 2011; 25: 1-6.
44. Hastan D, Fokkens WJ, Bachert C, Newson RB, Bislimovska J, Bockelbrink A, et al. Chronic rhinosinusitis in Europe-an underestimated disease. A GA(2)LEN study. Allergy 2011; 66: 1216-1223.
45. Tomassen P, Newson RB, Hoffmans R, Lotvall J, Cardell LO, Gunnbjornsdottir M, et al. Reliability of EP3OS symptom criteria and nasal endoscopy in the assessment of chronic rhinosinusitis-a GA(2) LEN study. Allergy 2011; 66: 556-561.
46. Van Crombruggen K, Zhang N, Gevaert P, Tomassen P, Bachert C,. Pathogenesis of chronic rhinosinusitis: inflammation. J Allergy Clin Immunol 2011; 128: 728-732.
47. Van Crombruggen K, Van Bruaene N, Holtappels G, Bachert C,. Chronic sinusitis and rhinitis: clinical terminology "Chronic Rhinosinusitis" further supported. Rhinology 2010; 48: 54-58.
48. Zhang N, Van Zele T, Perez-Novo C, Van Bruaene N, Holtappels G, DeRuyck N, et al. Different types of T-effector cells orchestrate mucosal inflammation in chronic sinus disease. J Allergy Clin Immunol 2008; 122: 961-968.
49. Van Zele T, Claeys S, Gevaert P, Van Maele G, Holtappels G, Van Cauwenberge P, et al. Differentiation of chronic sinus diseases by measurement of inflammatory mediators. Allergy 2006; 61: 1280-1289. (Pubitemid 44465587)
50. Kim YM, Munoz A, Hwang PH, Nadeau KC,. Migration of regulatory T cells toward airway epithelial cells is impaired in chronic rhinosinusitis with nasal polyposis. Clin Immunol 2010; 137: 111-121.
51. Ba L, Zhang N, Meng J, Zhang J, Lin P, Zhou P, et al. The association between bacterial colonization and inflammatory pattern in Chinese chronic rhinosinusitis patients with nasal polyps. Allergy 2011; 66: 1296-1303.
52. Shen Y, Tang XY, Yang YC, Ke X, Kou W, Pan CK, et al. Impaired balance of Th17/Treg in patients with nasal polyposis. Scand J Immunol 2011; 74: 176-185.
53. Cao PP, Li HB, Wang BF, Wang SB, You XJ, Cui YH, et al. Distinct immunopathologic characteristics of various types of chronic rhinosinusitis in adult Chinese. J Allergy Clin Immunol 2009; 124: 478-484, 484 e1-2.
54. Li X, Meng J, Qiao X, Liu Y, Liu F, Zhang N, et al. Expression of TGF, matrix metalloproteinases, and tissue inhibitors in Chinese chronic rhinosinusitis. J Allergy Clin Immunol 2010; 125: 1061-1068.
55. Kim JH, Kim JE, Choi GS, Kim HY, Ye YM, Park HS,. Serum cytokines markers in toluene diisocyanate-induced asthma. Respir Med 2011; 105: 1091-1094.
56. Wallwork B, Coman W, Mackay-Sim A, Cervin A,. Effect of clarithromycin on nuclear factor-kappa B and transforming growth factor-beta in chronic rhinosinusitis. Laryngoscope 2004; 114: 286-290. (Pubitemid 38182624)
57. Anandan C, Nurmatov U, van Schayck OC, Sheikh A,. Is the prevalence of asthma declining? Systematic review of epidemiological studies. Allergy 2010; 65: 152-167.
58. Howell JE, McAnulty RJ,. TGF-beta: its role in asthma and therapeutic potential. Curr Drug Targets 2006; 7: 547-565. (Pubitemid 43744822)
59. Duvernelle C, Freund V, Frossard N,. Transforming growth factor-beta and its role in asthma. Pulm Pharmacol Ther 2003; 16: 181-196. (Pubitemid 36794384)
60. Van Hove CL, Maes T, Joos GF, Tournoy KG,. Chronic inflammation in asthma: a contest of persistence vs resolution. Allergy 2008; 63: 1095-1109.
61. Zhang Y, Zhang J, Huang J, Li X, He C, Tian C, et al. Polymorphisms in the transforming growth factor-beta1 gene and the risk of asthma: a meta-analysis. Respirology 2010; 15: 643-650.
62. Ohno I, Nitta Y, Yamauchi K, Hoshi H, Honma M, Woolley K, et al. Transforming growth factor beta 1 (TGF beta 1) gene expression by eosinophils in asthmatic airway inflammation. Am J Respir Cell Mol Biol 1996; 15: 404-409. (Pubitemid 126439908)
63. Vignola AM, Chanez P, Chiappara G, Merendino A, Zinnanti E, Bousquet J, et al. Release of transforming growth factor-beta (TGF-beta) and fibronectin by alveolar macrophages in airway diseases. Clin Exp Immunol 1996; 106: 114-119. (Pubitemid 26329389)
64. Torrego A, Hew M, Oates T, Sukkar M, Fan Chung K,. Expression and activation of TGF-beta isoforms in acute allergen-induced remodelling in asthma. Thorax 2007; 62: 307-313. (Pubitemid 46580573)
65. Bottoms SE, Howell JE, Reinhardt AK, Evans IC, McAnulty RJ,. Tgf-Beta isoform specific regulation of airway inflammation and remodelling in a murine model of asthma. PLoS ONE 2010; 5: e9674.
66. O'Garra A, Stockinger B, Veldhoen M,. Differentiation of human T(H)-17 cells does require TGF-beta! Nat Immunol 2008; 9: 588-590. (Pubitemid 351712629)
67. Ryanna K, Stratigou V, Safinia N, Hawrylowicz C,. Regulatory T cells in bronchial asthma. Allergy 2009; 64: 335-347.
68. Lloyd CM, Hawrylowicz CM,. Regulatory T cells in asthma. Immunity 2009; 31: 438-449.
69. Shi HZ, Qin XJ,. CD4CD25 regulatory T lymphocytes in allergy and asthma. Allergy 2005; 60: 986-995.
70. Chen W, Jin W, Hardegen N, Lei KJ, Li L, Marinos N, et al. Conversion of peripheral CD4+ CD25- naive T cells to CD4+ CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3. J Exp Med 2003; 198: 1875-1886. (Pubitemid 38032120)
71. Kearley J, Robinson DS, Lloyd CM,. CD4+ CD25+ regulatory T cells reverse established allergic airway inflammation and prevent airway remodeling. J Allergy Clin Immunol 2008; 122: 617-624.
72. Joetham A, Takeda K, Taube C, Miyahara N, Matsubara S, Koya T, et al. Naturally occurring lung CD4(+)CD25(+) T cell regulation of airway allergic responses depends on IL-10 induction of TGF-beta. J Immunol 2007; 178: 1433-1442. (Pubitemid 46154614)
73. Nakao A, Miike S, Hatano M, Okumura K, Tokuhisa T, Ra C, et al. Blockade of transforming growth factor beta/Smad signaling in T cells by overexpression of Smad7 enhances antigen-induced airway inflammation and airway reactivity. J Exp Med 2000; 192: 151-158. (Pubitemid 30470298)
74. Scherf W, Burdach S, Hansen G,. Reduced expression of transforming growth factor beta 1 exacerbates pathology in an experimental asthma model. Eur J Immunol 2005; 35: 198-206. (Pubitemid 40123866)
75. Flood-Page P, Menzies-Gow A, Phipps S, Ying S, Wangoo A, Ludwig MS, et al. Anti-IL-5 treatment reduces deposition of ECM proteins in the bronchial subepithelial basement membrane of mild atopic asthmatics. J Clin Invest 2003; 112: 1029-1036. (Pubitemid 38056318)
76. Minshall EM, Leung DY, Martin RJ, Song YL, Cameron L, Ernst P, et al. Eosinophil-associated TGF-beta1 mRNA expression and airways fibrosis in bronchial asthma. Am J Respir Cell Mol Biol 1997; 17: 326-333. (Pubitemid 127500837)
77. Chakir J, Shannon J, Molet S, Fukakusa M, Elias J, Laviolette M, et al. Airway remodeling-associated mediators in moderate to severe asthma: effect of steroids on TGF-beta, IL-11, IL-17, and type I and type III collagen expression. J Allergy Clin Immunol 2003; 111: 1293-1298. (Pubitemid 36683685)
78. Cho JY, Miller M, Baek KJ, Han JW, Nayar J, Lee SY, et al. Inhibition of airway remodeling in IL-5-deficient mice. J Clin Invest 2004; 113: 551-560. (Pubitemid 38542504)
79. Dehzad N, Bopp T, Reuter S, Klein M, Martin H, Ulges A, et al. Regulatory T cells more effectively suppress Th1-induced airway inflammation compared with Th2. J Immunol 2011; 186: 2238-2244.
80. Lee CG, Cho SJ, Kang MJ, Chapoval SP, Lee PJ, Noble PW, et al. Early growth response gene 1-mediated apoptosis is essential for transforming growth factor beta1-induced pulmonary fibrosis. J Exp Med 2004; 200: 377-389. (Pubitemid 39031256)
81. McMillan SJ, Xanthou G, Lloyd CM,. Manipulation of allergen-induced airway remodeling by treatment with anti-TGF-beta antibody: effect on the Smad signaling pathway. J Immunol 2005; 174: 5774-5780. (Pubitemid 40593221)
82. Chen PF, Luo YL, Wang W, Wang JX, Lai WY, Hu SM, et al. ISO-1, a macrophage migration inhibitory factor antagonist, inhibits airway remodeling in a murine model of chronic asthma. Mol Med 2010; 16: 400-408.
83. Mabalirajan U, Aich J, Agrawal A, Ghosh B,. Mepacrine inhibits subepithelial fibrosis by reducing the expression of arginase and TGF-beta1 in an extended subacute mouse model of allergic asthma. Am J Physiol Lung Cell Mol Physiol 2009; 297: L411-L419.
84. Rabe KF, Hurd S, Anzueto A, Barnes PJ, Buist SA, Calverley P, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 2007; 176: 532-555. (Pubitemid 47403272)
85. Yao H, de Boer WI, Rahman I,. Targeting lung inflammation: novel therapies for the treatment of COPD. Curr Respir Med Rev 2008; 4: 57-68. (Pubitemid 351267004)
86. van Diemen CC, Postma DS, Vonk JM, Bruinenberg M, Nolte IM, Boezen HM,. Decorin and TGF-beta1 polymorphisms and development of COPD in a general population. Respir Res 2006; 7: 89.
87. Wu L, Chau J, Young RP, Pokorny V, Mills GD, Hopkins R, et al. Transforming growth factor-beta1 genotype and susceptibility to chronic obstructive pulmonary disease. Thorax 2004; 59: 126-129. (Pubitemid 38223483)
88. Gong Y, Fan L, Wan H, Shi Y, Shi G, Feng Y, et al. Lack of association between the TGF-beta(1) gene and development of COPD in Asians: a case-control study and meta-analysis. Lung 2011; 189: 213-223.
89. Hersh CP, Demeo DL, Lazarus R, Celedon JC, Raby BA, Benditt JO, et al. Genetic association analysis of functional impairment in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2006; 173: 977-984.
90. Castaldi PJ, Cho MH, Cohn M, Langerman F, Moran S, Tarragona N, et al. The COPD genetic association compendium: a comprehensive online database of COPD genetic associations. Hum Mol Genet 2010; 19: 526-534.
91. Brusselle GG, Joos GF, Bracke KR,. New insights into the immunology of chronic obstructive pulmonary disease. Lancet 2011; 378: 1015-1026.
92. Brozyna S, Ahern J, Hodge G, Nairn J, Holmes M, Reynolds PN, et al. Chemotactic mediators of Th1 T-cell trafficking in smokers and COPD patients. COPD 2009; 6: 4-16.
93. Sullivan AK, Simonian PL, Falta MT, Mitchell JD, Cosgrove GP, Brown KK, et al. Oligoclonal CD4+ T cells in the lungs of patients with severe emphysema. Am J Respir Crit Care Med 2005; 172: 590-596. (Pubitemid 41232970)
94. Barcelo B, Pons J, Ferrer JM, Sauleda J, Fuster A, Agusti AG,. Phenotypic characterisation of T-lymphocytes in COPD: abnormal CD4+ CD25+ regulatory T-lymphocyte response to tobacco smoking. Eur Respir J 2008; 31: 555-562.
95. Yang L, Ma QL, Yao W, Zhang Q, Chen HP, Wang GS, et al. Relationship between the anti-inflammatory properties of salmeterol/fluticasone and the expression of CD4+ CD25+ Foxp3+ regulatory T cells in COPD. Respir Res 2011; 12: 142.
96. Xiong XZ, Jin Y, Zhou Q, Zhang XJ, Du W, Liu W, et al. [Correlation between FoxP3(+) regulatory T cells and chronic obstructive pulmonary disease]. Zhonghua Yi Xue Za Zhi 2008; 88: 471-474. (Pubitemid 351689139)
97. Lee SH, Goswami S, Grudo A, Song LZ, Bandi V, Goodnight-White S, et al. Antielastin autoimmunity in tobacco smoking-induced emphysema. Nat Med 2007; 13: 567-569. (Pubitemid 46828488)
98. Isajevs S, Taivans I, Strazda G, Kopeika U, Bukovskis M, Gordjusina V, et al. Decreased FOXP3 expression in small airways of smokers with COPD. Eur Respir J 2009; 33: 61-67.
99. Takizawa H, Tanaka M, Takami K, Ohtoshi T, Ito K, Satoh M, et al. Increased expression of transforming growth factor-beta1 in small airway epithelium from tobacco smokers and patients with chronic obstructive pulmonary disease (COPD). Am J Respir Crit Care Med 2001; 163: 1476-1483. (Pubitemid 32506619)
100. Springer J, Scholz FR, Peiser C, Groneberg DA, Fischer A,. SMAD-signaling in chronic obstructive pulmonary disease: transcriptional down-regulation of inhibitory SMAD 6 and 7 by cigarette smoke. Biol Chem 2004; 385: 649-653. (Pubitemid 39144947)
101. Churg A, Cosio M, Wright JL,. Mechanisms of cigarette smoke-induced COPD: insights from animal models. Am J Physiol Lung Cell Mol Physiol 2008; 294: L612-L631. (Pubitemid 351520094)